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ABSTRACT 
 
 
 
It has been reported that cocaine and amphetamine-regulated transcript (CART) peptides can 
increase locomotor activity and produce a conditioned place preference. To establish whether 
or not CART can be consider as a valuable marker of addiction we performed a comparative 
study of the expression of CART gene by several drugs of abuse. This was achieved using 
real-time quantitative PCR in four rat brain structures: prefrontal cortex, caudate putamen, 
nucleus accumbens and hippocampus. As expected, a significant induction of the immediate 
early gene c-fos was observed after acute administration of morphine, cocaine, 3, 4-
methylenedioxymethamphetamine and Δ9-Tetrahydrocannabinol. On the contrary none of 
these drugs was able to produce a significant change in CART mRNA levels demonstrating 
that the expression of this gene is not modulated by the four drugs of abuse in these brain 
structures. 
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Cocaine- and amphetamine- regulated transcript (CART) was initially isolated by PCR 
differential display as an up-regulated mRNA in the rat striatum following acute 
psychostimulant-drug administration [4]. CART mRNA and CART peptides are expressed 
throughout the mammalian brain as shown by immunohistochemical and in situ hybridization 
studies [2, 4, 13, 14]. In the rat, alternative splicing produce two CART peptides (116 and 129 
amino acids) [4], which are tissue-specifically processed into several fragments. It has been 
shown that the C-terminal region, CART(55-102), is sufficient to obtain a biological activity 
[16].  
Neuro-anatomical and behavioral studies have confirmed the implication of CART in the 
control of appetite in the last few years (review in [10, 15]). On the other hand, CART 
peptides and CART mRNA, were found in brain structures associated with drug-induced 
reward and reinforcement such as the nucleus accumbens [4]. All drugs of abuse induce an 
increase of dopamine in this region [3], although these drugs have different mechanisms of 
action (review in [18]). Some of them target dopamine and/or serotonine transporters like 
cocaine and 3, 4-methylenedioxymethamphetamine (MDMA). Others interact with specific 
receptors like morphine or Δ9-Tetrahydrocannabinol (Δ9-THC). Nevertheless, all drugs of 
abuse induce hyperlocomotion and activate the reward pathway which includes dopaminergic 
neurons in the ventral-tegmental area (VTA) and their direct or relayed projections to nucleus 
accumbens (N. Acc), amygdala, prefrontal cortex (PFC) and other forebrain regions. 
Interistingly, Kimmel et al, have recently shown that injection of CART(55-102) into the 
VTA of rats induced locomotor activity and a slight conditioned place preference [11, 12] 
suggesting that two of the most important behavorial responses of all drugs of abuse could be 
induced by CART itself: Based on these results it was interesting to to test the possible role of 
CART as a common effector of drugs of abuse such as morphine, cocaine, MDMA and Δ9-
THC. 
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This was investigated by using real time quantitative RT-PCR to measure the expression of 
the CART gene. The immediate early gene c-fos which is a marker of neuronal activation is 
overexpressed by these drugs in rat brain [7, 8, 17, 19] and was used here as a positive 
control. Moreover, we have examined the levels of CART mRNA in different structures 
implicated in memory, locomotion and reward to test the specificity of CART induction by the 
four drugs of abuse.  
Male Sprague-Dawley rats (250-300 g) were used (Charles-Rivers, France). Experiments 
were performed according to the European Communities Concil Directive (86/609/EEC). 
Animals were housed under controlled conditions (12h alterning light/dark cycle and 21+1°C) 
and had free access to food and water. Morphine (Francopia, France), cocaine (Sigma, 
France) and MDMA (Lipomed, Switzerland) were dissolved in 0.9% saline and Δ9−THC 
(Sigma, France) in 80% saline, 10% EtOH, 10% cremophor (Sigma, France). The rats 
received a single 0.1 ml/100g intraperitoneal (i. p.) injection of morphine (20 mg/kg; n = 4), 
cocaine (20 mg/kg; n = 4), MDMA (10mg/kg; n = 5) or Δ9−THC (5 mg/kg; n =3). Controlled 
rats received 0.9% saline or vehicle i.p. Immediately after the injection, the rats were placed 
in their home cages and grouped according to the substance administered. One hour after the 
injection, the animals were killed by decapitation and the four brain structures were rapidly 
dissected : prefrontal cortex (PFC), caudate putamen (CPu), nucleus accumbens (N. Acc) and 
hippocampus. The tissues were frozen in isopentane at –50°C and stored at –80°C until use.  
The theoretical and practical aspects of real-time quantitative RT-PCR using the ABI 
Prism 7700 Sequence Detection System (Applied Biosystems) have been described elsewhere 
[1]. Briefly, total RNA extracted from frozen tissues is reverse-transcribed before real-time 
PCR amplification. Quantitative values are obtained from the threshold cycle (Ct) number at 
which the increase in the signal associated with exponential growth of PCR products begins to 
be detected using PE Biosystems analysis software, according to manufacturer 
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recomandations. The precise amount of total RNA added to each reaction mix (based on 
optical density) and its quality (lack of extensive degradation) are both difficult to assess. We 
therefore also quantified transcripts of the RPLP0 gene encoding the rat acidic ribosomal 
phosphoprotein P0 as the endogenous RNA control, and each sample was normalized on the 
basis of its RPLP0 content. 
As described, [1] differences in target gene expression (c-fos or CART) relative to the 
RPLP0 gene, termed Ntarget were determined by the formula Ntarget =2ΔCtsample, where ΔCt 
value of the sample was determined by substracting the average Ct value of the target gene 
from the average Ct value of the RPLP0 gene. The Ntarget values of the samples (drug-treated 
and controls) were then subsequently normalized to a calibrator consisting of a naïve rat brain 
tissue sample. The nucleotide sequences of the specific primers used are shown in table I. 
PCR was performed using the SYBR® Green PCR Core Reagents kit (Perkin Elmer Applied 
Biosystems). The thermal cycling conditions comprised an initial denaturation step at 95°C 
for 10 min and 50 cycles at 95°C for 15s and 65°C for 1 min  
The quantification were performed in duplicate on a pool of structures from 6 animals for 
each point, the results represents the mean value + SEM of 4 independent experiments. One-
way analysis of variance (ANOVA), followed by Student’s t test, was used for the statistical 
evaluation. The level of significance was chosen as P<0.05. 
As compared to the controls, acute treatment with morphine, cocaine, Δ9−THC and 
MDMA led to a significant increase in c-fos mRNA in the CPu (1.4; 6.84; 2.52 and 5.44 fold 
respectively). Similarly all the tested drugs induced a marked increase in the mRNA level of 
this gene in the hippocampus (1.48; 2; 1.62 and 2.18 fold respectively). However, the 
modulation of c-fos mRNA was significantly induced in the PFC by three of the tested drugs : 
cocaine, Δ9−THC and MDMA (2.11; 2.26 and 4.2 fold respectively). These three drugs also 
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induced a significant increase of this mRNA in the N. Acc (2.26; 2.11 and 3.9 fold 
respectively).  
These results are in accordance with those of Erdtmann-Vourliotis et al. (1999) [5] who 
showed by in situ hybridization that drugs with low addictive potential like Δ9−THC and 
MDMA induced a larger increase in c-fos mRNA than morphine or cocaine. Thus the 
quantitative RT-PCR protocol used in the present study appears to be a satisfactory method to 
quantify the modulation of genes after drug treatments. 
Therefore this method was used to evaluate the possible modulation of CART mRNA level 
following treatments by the four drugs chosen (Fig. 2). Surprisingly, one injection of cocaine 
did not lead to a significant increase of CART in any of the structures studied: N. Acc, CPu, 
PFC and hippocampus (Fig. 2). Moreover, none of the four drugs appear to significantly 
modulate CART mRNA in any of the selected cerebral structures (Fig. 2). However, there is a 
slight but not significant increase in CART mRNA in the N. Acc of the rats treated with 
MDMA. In this study we could not detect a significant modulation of CART in any of the two 
major components of the striatum (N. Acc and CPu). Furthermore, we did not see any 
regulation of CART mRNA with repeated fifteen daily doses of cocaine (data not shown). 
Moreover, in the case of the amphetamine-derived compound (MDMA) no significant 
modulation of this gene was observed.  
Our study showed that the modulation of c-fos by different drugs of abuse can be assessed 
by real-time quantitative RT-PCR. The results obtained are consistent in range and 
localization with those obtained previously [5]. However, although we used strictly the same 
protocol of cocaine injection as Douglass et al [4] we did not find any regulation of CART by 
this drug and by any of the drugs tested. These authors reported a 4-5 fold increase in CART 
mRNA in rat striatum using Northern blot analysis. Here, we could detect as little as 1.6 fold 
increase in c-fos mRNA. Thus, the absence of regulation seen here is clearly not a limitation 
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of the method used. It can be proposed that the increase in CART mRNA may be localized in 
a subset of neurons or a certain area of the striatum. However, Vrang and al [20] reported 
recently that in similar conditions as those used here they could not detect any modulation of 
CART by amphetamine using in situ hybridization. Moreover, except for the original report on 
amphetamine and cocaine only two other publications examined the effects of cocaine on 
CART expression. One of them reported a modest increase of CART mRNA in the N. Acc of 
female rats after binge injections of cocaine [6]. The other one reported that cocaine had no 
effect on the expression of CART in the N. Acc [9]. Taken together these results and those 
obtained in this study with extension to other drugs of abuse raise the question of the 
relevance of the modulation of CART by drugs of abuse including psychostimulants.  
CART peptides have been discovered in 1995 as psychostimulants regulated peptides but 
their implication in drug addiction appears unlikely. This does not impede the interest of 
CART peptides in feeding modulation as shown by several groups. 
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LEGENDS 
 
 
Figure 1 : Real-time quantitative RT-PCR analysis of the effect of acute injection of 
morphine (20 mg/kg), cocaine (20 mg/kg), Δ9−THC (10 mg/kg) and MDMA (10 mg/kg) on c-
fos mRNA level in the different brain structures tested (N. Acc, Cpu, PFC and hippocampus). 
 saline,  drug. Data are the means + SEM. *P<0.05, **P<0.01, ***P<0.001 by the 
Student’s t-test (n = 4) 
 
Figure 2 : Real-time quantitative RT-PCR analysis of the effect of acute injection of 
morphine (20 mg/kg), cocaine (20 mg/kg), Δ9−THC (10 mg/kg) and MDMA (10 mg/kg) on 
CART mRNA level in the different brain structures tested (N. Acc, Cpu, PFC and 
hippocampus).  saline,  drug. Data are the means + SEM (n = 4) 
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Genes Oligonucleotide Sequence Amplicon 
size 
RPLP0 Forward primer 
Reverse primer 
5'-GGCGACCTGGAAGTCCAACT-3' 
5'-CCATCAGCACCACAGCCTTC-3' 
149 bp 
CART Forward primer 
Reverse primer 
5’-GCCAAGTCCCCATGTGTGAC-3’ 
5’-CACCCCTTCACAAGCACTTCA-3’ 
129 bp 
c-fos Forward primer 
Reverse primer 
5’-GGCAAAGTAGAGCAGCTATCTCCT-3’ 
5’-TCAGCTCCCTCCTCCGATTC-3’ 
106 bp 
 
Table I : Primers sequences used. Primers were chosen with the assistance of Oligo 6™ 
software. CART primers were chosen in the region of the cDNA corresponding to the C-
terminal part of the protein which shows physiological activity. c-fos and RPLP0 primers 
were chosen on different exons or at exon boundaries in order to avoid amplification of 
putative contaminating genomic DNA. 
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